BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36254028)

  • 1. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor.
    Wang J; Feng ZX; Ren T; Meng WY; Khan I; Fan XX; Pan HD; Liu L; Tang YJ; Yao XJ; Li RZ; Wang MF; Leung EL
    Medicine (Baltimore); 2022 Oct; 101(41):e31027. PubMed ID: 36254028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.
    Zhao T; Zhang J; Zhang X; Wang C
    BMC Pulm Med; 2024 May; 24(1):241. PubMed ID: 38750432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
    Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
    BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study.
    Fei G; Yijun M; Weijiang J; Huimin C; Fang L
    BMC Infect Dis; 2023 Nov; 23(1):771. PubMed ID: 37940883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.
    Lin L; Li S; Xiong Q; Wang H
    BMC Pulm Med; 2021 Mar; 21(1):95. PubMed ID: 33740937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion.
    Liu Y; Ou Q; Zheng J; Shen L; Zhang B; Weng X; Shao L; Gao Y; Zhang W
    Emerg Microbes Infect; 2016 Aug; 5(8):e83. PubMed ID: 27485497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion.
    Shu CC; Wang JY; Hsu CL; Keng LT; Tsui K; Lin JF; Lai HC; Yu CJ; Lee LN; Luh KT
    Respirology; 2015 Jan; 20(1):147-54. PubMed ID: 25355638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.
    Zhang F; Hu L; Wang J; Chen J; Chen J; Wang Y
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27976800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
    Gao J; Song L; Li D; Peng L; Ding H
    Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion.
    Rabbi MF; Ahmed MN; Patowary MSA; Huq SR; Razzaque SMA; Arafat HM; Nahar T; Iktidar MA
    BMC Pulm Med; 2023 Sep; 23(1):349. PubMed ID: 37715196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
    Yildiz PB; Yazar EE; Gorgun D; Secik F; Cakir G
    Asian Pac J Cancer Prev; 2011; 12(2):419-23. PubMed ID: 21545206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
    Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
    J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
    Wang T; Wang N; Zhang L; Liu Y; Thakur A
    Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
    Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
    Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of D-dimer in predicting pulmonary embolism in tuberculous pleural effusion patients.
    Li X; Qin Y; Ye W; Chen X; Sun D; Guo X; Gu W
    BMC Pulm Med; 2021 May; 21(1):177. PubMed ID: 34022828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
    Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
    J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion.
    Du J; Shao MM; Yi FS; Huang ZY; Qiao X; Chen QY; Shi HZ; Zhai K
    Microbiol Spectr; 2022 Aug; 10(4):e0255321. PubMed ID: 35880892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion.
    Dalil Roofchayee N; Marjani M; Dezfuli NK; Tabarsi P; Moniri A; Varahram M; Adcock IM; Mortaz E
    Sci Rep; 2021 Jan; 11(1):660. PubMed ID: 33436672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
    Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
    Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.